Pomalidomide plus Low-Dose Dexamethasone in Patients with Refractory or Relapsed and Refractory Multiple Myeloma and Renal Impairment: Analysis of Patients from the Phase 3b Stratus Trial (MM-010)

被引：0

作者：

Weisel, Katja ^{[1
]}

Dimopoulos, Meletios A. ^{[2
]}

Cavo, Michele ^{[3
]}

Ocio, Enrique M. ^{[4
]}

Palumbo, Antonio ^{[5
]}

Corradini, Paolo ^{[6
]}

Delforge, Michel ^{[7
]}

Oriol, Albert ^{[8
]}

Goldschmidt, Harmut ^{[9
]}

Conticello, Concetta ^{[10
]}

Vacca, Angelo ^{[11
]}

Hansson, Markus ^{[12
]}

Miller, Neil ^{[13
]}

Peluso, Teresa ^{[13
]}

Sternas, Lars ^{[14
]}

Zaki, Mohamed H. ^{[14
]}

Moreau, Philippe ^{[15
]}

机构：

[1] Univ Tubingen Hosp, Tubingen, Germany

[2] Univ Athens, Sch Med, GR-11527 Athens, Greece

[3] Univ Bologna, Sch Med, Bologna, Italy

[4] Hosp Univ Salamanca IBSAL, Salamanca, Spain

[5] Univ Turin, Myeloma Unit, Div Hematol, Turin, Italy

[6] Fdn IRCCS Ist Nazl Tumori, Milan, Italy

[7] Univ Hosp Leuven, Leuven, Belgium

[8] Hosp Badalona Germans Trias & Pujol, Barcelona, Spain

[9] Univ Clin Heidelberg, Heidelberg, Germany

[10] Univ Catania, Sch Med, Catania, Italy

[11] Univ Bari, Sch Med, Bari, Italy

[12] Lund Univ, Skane Univ Hosp, Lund, Sweden

[13] Celgene Corp, Boudry, Switzerland

[14] Celgene Corp, Summit, NJ USA

[15] Univ Hosp Nantes, Nantes, France

来源：

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：4